Kim D. JANDA,Nicholas T. JACOB,Jonathan W. LOCKNER
申请号：
US16848032
公开号：
US20200283440A1
申请日:
2020.04.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
There are disclosed imidazolinopyrimidinone compounds that have activity to induce TRAIL gene expression in macrophages. There is further disclosed a method for treating various cancers comprising administering effective amounts of an imidazolinopyrimidinone having the structure of Formula I herein.
